Estar Medical

Company Overview

Snapshot

Founded in January 1992 by Aaron Esteron, Estar Medical operates with 11–50 employees. The company focuses on developing advanced medical technologies.

Business overview

Estar Medical specializes in developing patented platform methods for producing autologous platelet-rich plasma and related cell therapy technologies for human use. Operating under the registered trademarks Tropocells and Cellenis, the company's technology processes a patient's own blood to utilize platelets, cells, and essential proteins across various medical disciplines. These include dermatology, aesthetics, orthopedics, sports medicine, wound care, pain management, dental, ophthalmology, and veterinary. Estar Medical's products, which are US FDA cleared for orthopedic applications, CE certified (Class IIb), and ISO 13485 approved, can be used independently or to complement other biological and therapeutic methods.

Strategic signal

In August 2019, Estar Medical announced that Regenlab was in breach of UK court orders following the revocation of its PRP patent. This event signals Estar Medical's proactive stance in protecting its intellectual property and asserting its market position in the platelet-rich plasma technology sector, indicating a commitment to defending its proprietary technology against competitors.

Company Intelligence Q&A

What is Estar Medical's core technology?

Estar Medical's core technology involves a patented platform method for producing autologous platelet-rich plasma and other related cell therapy technologies for human use, distributed under the Tropocells and Cellenis trademarks.

What medical applications do Estar Medical's products serve?

Estar Medical's products are applied in various medical disciplines, including dermatology, aesthetics, orthopedics, sports medicine, wound care, pain management, dental, ophthalmology, and veterinary.

What certifications and approvals do Estar Medical's products hold?

Estar Medical's Tropocells and Cellenis product portfolio is based on proprietary patented technology that is US FDA cleared for orthopedic applications, CE certified (Class IIb), and ISO 13485 approved.

When was Estar Medical founded?

Estar Medical was founded in January 1992.

What was a notable legal development for Estar Medical in 2019?

In August 2019, Estar Medical reported that Regenlab was in breach of UK court orders following the revocation of its PRP patent.